UTAMAMALAYSIADUNIAPOLITIKVIDEOHIBURANSUKANGAYA HIDUPBISNESENGLISHPODCASTFOTORANCANGANTEKNOLOGI

Carian mengenai topik moderna-inc

Dapatkan berita terkini mengenai moderna-inc dari Astro Awani

US COVID vaccines start to roll out for young children

US COVID vaccines start to roll out for young children

US regulators authorised Moderna Inc's two-dose vaccine for children aged six months to five years.
Wed Jun 22 2022
Moderna rancang tubuh anak syarikat baharu di Malaysia

Moderna rancang tubuh anak syarikat baharu di Malaysia

Syarikat bioteknologi yang merintis terapeutik dan vaksin messenger RNA (mRNA), Moderna, Inc. hari ini mengumumkan rancangan untuk menubuhkan anak syarikat baharu di Malaysia, disertai tiga anak syari
Wed Feb 16 2022
Singapore not counting Sinovac shots in COVID-19 vaccination tally

Singapore not counting Sinovac shots in COVID-19 vaccination tally

Currently, this only includes those vaccinated with the Moderna Inc and Pfizer-BioNTech/Cominarty vaccines.
Wed Jul 07 2021
Millions of COVID vaccine doses on the way for Taiwan, alert level extended

Millions of COVID vaccine doses on the way for Taiwan, alert level extended

Taiwan has ordered more than 20 million doses from AstraZeneca Plc and Moderna Inc and is also developing its own vaccines.
Tue May 25 2021
Factbox : When and which COVID-19 vaccines are likely to be available in Asia

Factbox : When and which COVID-19 vaccines are likely to be available in Asia

Regulators in Asia are weighing approval for COVID-19 vaccines developed by Pfizer with partner BioNTech SE, Moderna Inc and AstraZeneca.
Thu Jan 07 2021
Pfizer seeks emergency approval for COVID-19 vaccine in India, media say

Pfizer seeks emergency approval for COVID-19 vaccine in India, media say

Pfizer Inc has applied for emergency use authorisation of its coronavirus vaccine in India, media said on Sunday.
Sun Dec 06 2020
Moderna CEO confident of producing 500 million COVID-19 vaccine doses in 2021

Moderna CEO confident of producing 500 million COVID-19 vaccine doses in 2021

Moderna Inc will be able to produce 500 million doses of its COVID-19 vaccine in 2021.
Sat Dec 05 2020
Moderna to supply up to 125 million COVID-19 vaccine doses globally in first quarter

Moderna to supply up to 125 million COVID-19 vaccine doses globally in first quarter

The first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture globally in 2021.
Fri Dec 04 2020
COVID-19: Moderna kemuka kelulusan kecemasan vaksin daripada FDA selepas capai tahap keberkesanan 94.1%

COVID-19: Moderna kemuka kelulusan kecemasan vaksin daripada FDA selepas capai tahap keberkesanan 94.1%

Moderna Inc akan mengemukakan permohonan kebenaran kecemasan daripada Pentadbiran Makanan dan Ubat-Ubatan (FDA) untuk menggunakan penghasilan vaksinnya.
Mon Nov 30 2020
Pharmaniaga siap siaga edar vaksin COVID-19

Pharmaniaga siap siaga edar vaksin COVID-19

Pharmaniaga Berhad (Pharmaniaga) telah menubuhkan pasukan petugas dan bersedia mengedarkan vaksin COVID-19 ke seluruh negara yang dijangka boleh didapati pada suku pertama tahun depan.
Mon Nov 30 2020
Explainer: When and how will COVID-19 vaccines become available?

Explainer: When and how will COVID-19 vaccines become available?

If regulators approve any vaccines in coming weeks, the distribution could begin almost immediately with governments around the world deciding who gets them and in what order.
Wed Nov 25 2020
Moderna dakwa vaksinnya 94.5 peratus berkesan

Moderna dakwa vaksinnya 94.5 peratus berkesan

Ia sekali gus menjadikan Moderna sebagai syarikat AS kedua dalam masa seminggu untuk melaporkan keputusan yang memberangsangkan.
Mon Nov 16 2020
Moderna says its vaccine is 94.5% effective in preventing COVID-19

Moderna says its vaccine is 94.5% effective in preventing COVID-19

Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial.
Mon Nov 16 2020
Next crop of COVID-19 vaccine developers take more traditional route

Next crop of COVID-19 vaccine developers take more traditional route

Many leading candidates in final-stage test are based on new, largely unproven technology platforms designed to produce vaccines at speed.
Thu Oct 29 2020
Oxford and AstraZeneca resume coronavirus vaccine trial

Oxford and AstraZeneca resume coronavirus vaccine trial

Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca.
Sun Sep 13 2020